Striatal adenylate cyclase activity following reserpine and chronic chlorpromazine administration in rats.
D000262:Adenylyl Cyclases / Q000378:metabolism*; D000818:Animals; D002746:Chlorpromazine / Q000494:pharmacology*; D003342:Corpus Striatum / Q000187:drug effects / Q000201:enzymology* / Q000378:metabolism; D000242:Cyclic AMP / Q000378:metabolism; D004298:Dopamine / Q000494:pharmacology; D018492:Dopamine Antagonists; D004305:Dose-Response Relationship, Drug; D005476:Fluphenazine / Q000494:pharmacology; D008297:Male; D009638:Norepinephrine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D051381:Rats; D011955:Receptors, Drug / Q000187:drug effects; D012110:Reserpine / Q000494:pharmacology*; D009435:Synaptic Transmission / Q000187:drug effects
D018492:Dopamine Antagonists; D011955:Receptors, Drug; D012110:Reserpine; D000242:Cyclic AMP; D000262:Adenylyl Cyclases; D005476:Fluphenazine; D002746:Chlorpromazine; D004298:Dopamine; D009638:Norepinephrine